Retraction: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma

PLOS ONE Editors. PLoS One. 2021.

. 2021 Apr 13;16(4):e0250313.

doi: 10.1371/journal.pone.0250313. eCollection 2021.

No abstract available

Retraction of

miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
Lv M, Zhang X, Li M, Chen Q, Ye M, Liang W, Ding L, Cai H, Fu D, Lv Z. Lv M, et al. PLoS One. 2013 Jul 5;8(7):e67591. doi: 10.1371/journal.pone.0067591. Print 2013. PLoS One. 2013. Retraction in: PLoS One. 2021 Apr 13;16(4):e0250313. doi: 10.1371/journal.pone.0250313. PMID: 23861775 Free PMC article. Retracted.

MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
Wu Z, Lu B, Li X, Miao W, Li J, Shi Y, Yu W. Wu Z, et al. Clin Exp Pharmacol Physiol. 2018 May;45(5):444-451. doi: 10.1111/1440-1681.12890. Epub 2018 Jan 8. Clin Exp Pharmacol Physiol. 2018. PMID: 29143362
LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
Zhang XM, Wang J, Liu ZL, Liu H, Cheng YF, Wang T. Zhang XM, et al. Biosci Rep. 2020 Jun 26;40(6):BSR20200525. doi: 10.1042/BSR20200525. Biosci Rep. 2020. PMID: 32426838 Free PMC article.
MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
Hua K, Jin J, Zhang H, Zhao B, Wu C, Xu H, Fang L. Hua K, et al. Int J Oncol. 2016 Oct;49(4):1531-1540. doi: 10.3892/ijo.2016.3660. Epub 2016 Aug 18. Int J Oncol. 2016. PMID: 27633373
MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.
Gong Y, Wu W, Zou X, Liu F, Wei T, Zhu J. Gong Y, et al. Am J Cancer Res. 2018 Jun 1;8(6):1030-1039. eCollection 2018. Am J Cancer Res. 2018. PMID: 30034940 Free PMC article.
MicroRNA-26a: An Emerging Regulator of Renal Biology and Disease.
Li X, Pan X, Fu X, Yang Y, Chen J, Lin W. Li X, et al. Kidney Blood Press Res. 2019;44(3):287-297. doi: 10.1159/000499646. Epub 2019 Jun 4. Kidney Blood Press Res. 2019. PMID: 31163420 Review.

1. Lv M, Zhang X, Li M, Chen Q, Ye M, Liang W, et al.. (2013) miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma. PLoS ONE 8(7): e67591. 10.1371/journal.pone.0067591 - DOI - PMC - PubMed